Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of everolimus- and paclitaxel-eluting stents in dialysis patients.
Otsuka M, Shiode N, Masaoka Y, Okimoto T, Tamekiyo H, Kawase T, Yamane K, Kagawa Y, Hironobe N, Higashihara T, Fujii Y, Hayashi Y. Otsuka M, et al. Among authors: shiode n. Cardiovasc Revasc Med. 2015 Jun;16(4):208-12. doi: 10.1016/j.carrev.2015.04.005. Epub 2015 Apr 20. Cardiovasc Revasc Med. 2015. PMID: 25953112
Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation.
Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, Nishikawa H, Hiasa Y, Muramatsu T, Meguro T, Inoue N, Honda H, Hayashi Y, Miyazaki S, Oshima S, Honda T, Shiode N, Namura M, Sone T, Nobuyoshi M, Kita T, Mitsudo K; j-Cypher Registry Investigators. Kimura T, et al. Among authors: shiode n. Circulation. 2009 Feb 24;119(7):987-95. doi: 10.1161/CIRCULATIONAHA.108.808311. Epub 2009 Feb 9. Circulation. 2009. PMID: 19204304
Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry).
Nakagawa Y, Kimura T, Morimoto T, Nomura M, Saku K, Haruta S, Muramatsu T, Nobuyoshi M, Kadota K, Fujita H, Tatami R, Shiode N, Nishikawa H, Shibata Y, Miyazaki S, Murata Y, Honda T, Kawasaki T, Doi O, Hiasa Y, Hayashi Y, Matsuzaki M, Mitsudo K; j-Cypher Registry Investigators. Nakagawa Y, et al. Among authors: shiode n. Am J Cardiol. 2010 Aug 1;106(3):329-36. doi: 10.1016/j.amjcard.2010.03.031. Epub 2010 Jun 18. Am J Cardiol. 2010. PMID: 20643241
Comparison of target-lesion revascularisation between left main coronary artery bifurcations and left anterior descending coronary artery bifurcations using the one and two stent approach with sirolimus-eluting stents.
Toyofuku M, Kimura T, Morimoto T, Hayashi Y, Shiode N, Okimoto T, Otsuka M, Tamekiyo H, Tamura T, Kadota K, Inoue K, Mitsudo K; j-Cypher Registry investigators. Toyofuku M, et al. Among authors: shiode n. EuroIntervention. 2011 Nov;7(7):796-804. doi: 10.4244/EIJV7I7A126. EuroIntervention. 2011. PMID: 22082575 Free article.
Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.
Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, Muramatsu T, Shiode N, Namura M, Sone T, Oshima S, Nishikawa H, Hiasa Y, Hayashi Y, Nobuyoshi M, Mitudo K; j-Cypher Registry Investigators. Kimura T, et al. Among authors: shiode n. Circulation. 2012 Jan 31;125(4):584-91. doi: 10.1161/CIRCULATIONAHA.111.046599. Epub 2011 Dec 27. Circulation. 2012. PMID: 22203694
Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial.
Natsuaki M, Kozuma K, Morimoto T, Kadota K, Muramatsu T, Nakagawa Y, Akasaka T, Igarashi K, Tanabe K, Morino Y, Ishikawa T, Nishikawa H, Awata M, Abe M, Okada H, Takatsu Y, Ogata N, Kimura K, Urasawa K, Tarutani Y, Shiode N, Kimura T; NEXT Investigators. Natsuaki M, et al. Among authors: shiode n. J Am Coll Cardiol. 2013 Jul 16;62(3):181-190. doi: 10.1016/j.jacc.2013.04.045. Epub 2013 May 15. J Am Coll Cardiol. 2013. PMID: 23684673 Free article. Clinical Trial.
94 results